Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : Z

Records returned : 15 (on 29 May 2025 at 00:50:59).

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Zanamivir

Drug:

Zanamivir

Indication :

Influenza

Status :

Green

Formulations :

Inhalation

Restrictions / Comments:

Important

recommended for treatment of influenza in adults and children meeting the criteria set out in NICE TA 168 and for prophylaxis of influenza in adults and children meeting the criteria set out in NICE TA 158

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Zanamivir

Drug:

Zanamivir

Indication :

Influenza

Status :

Red

Formulations :

Infusion

Restrictions / Comments:

Important

Restricted antimicrobial - to be used on advice of microbiologist

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Ziconotide acetate

Drug:

Ziconotide acetate

Indication :

Pain

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NHSE

4. Zidovudine

Drug:

Zidovudine

Indication :

HIV infection

Status :

Red

Formulations :

Capsules
Oral solution

Restrictions / Comments:

Important

Restricted Antimicrobial - requires GUM Specialist approval

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

5. Zidovudine

Drug:

Zidovudine

Indication :

Prevention of HIV vertical transmission

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Important

Restricted use - prevention of vertical transmission in babies born to HIV-positive mothers. Use as recommended in BHIVA guidelines

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

6. Zoledronic acid

Drug:

Zoledronic acid

Indication :

Malignancy

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Important

4mg infusion.
Hypercalcaemia of malignancy. Bone metastases. Prevention of skeletal events.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Zoledronic acid

Drug:

Zoledronic acid

Indication :

Osteoporosis

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Important

5mg annual infusion

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

8. Zoledronic acid

Drug:

Zoledronic acid

Indication :

Paget's disease

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Important

5mg infusion.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

9. Zolmitriptan

Drug:

Zolmitriptan

Indication :

Cluster headaches

Status :

Green (see narrative)

Formulations :

Nasal spray

Restrictions / Comments:

Important

Prescribe generically. Off-label use.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

10. Zolmitriptan

Drug:

Zolmitriptan

Indication :

Menstrual related migraine

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Off-label. Use if inadequate response to standard acute migraine treatments.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

11. Zolmitriptan

Drug:

Zolmitriptan

Indication :

Migraine (acute)

Status :

Green

Formulations :

Nasal spray
Tablets

Restrictions / Comments:

Important

Preferred

Prescribe generically

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

12. Zolmitriptan

Drug:

Zolmitriptan

Indication :

Migraine (acute)

Status :

Green (see narrative)

Formulations :

Oro-dispersible

Restrictions / Comments:

Important

Prescribe generically

Use orodispersible tablets in patients with swallowing difficulties, nausea or vomitting.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

13. Zonisamide

Drug:

Zonisamide

Indication :

Epilepsy

Status :

Blue

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

14. Zonisamide

Drug:

Zonisamide

Indication :

Epilepsy

Status :

Blue

Formulations :

Oral suspension

Restrictions / Comments:

Important

Zonisamide 20mg/ml is the only licensed oral suspension available.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

15. Zuclopenthixol decanoate

Drug:

Zuclopenthixol decanoate

Indication :

Schizophrenia and other psychoses

Status :

Amber

Formulations :

Depot injection

Restrictions / Comments:

Important

This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.

Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC